Log no. JW140042

Ended Definitive Contract Awarded Last action

Contract number
W81XWH15C0101
Awardee
Awarding agency
Obligated
$3,558,603

Award facts

Opportunity
  • W81XWH14RWMRP Solicitation number
Contract value 100% obligated
$3,558,603.15 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Basic Research
Pricing
Cost Plus Fixed Fee
Place of performance
Buffalo, NY 14203, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00008 · Proposal log no. JW140042 $0
Funding Only Action P00007 · Proposal log no. JW140042 6.3 funding -$604,262
Change Order P00006 · Proposal log no. JW140042 study of survival efficacy of entolimod and sargramostim in rhesus macaques 6.3 funding -$5,063,589
Change Order P00005 · Proposal log no. JW140042 advanced development of entolimod to mitigate and treat the acute effects of ionizing radiation $0
Other Administrative Action P00004 · Research involves the continued preclinical development of entolimod (CBLB502) as a medical radiation countermeasure (MRC) for reducing the risk of death… $0
Other Administrative Action P00003 · NCE $0
Other Administrative Action P00002 · Update invoice instructions $0
Additional Work (new agreement, FAR part 6 applies) P00001 · Incorporate SOW change JW140042 $0
Original award $9,226,455

About this award

Written by GovTribe AI ·

This is a cost-plus-fixed-fee definitive contract awarded by the Defense Health Agency, a defense agency, to Cleveland Biolabs, Inc. The contract has a ceiling value of $3,558,603.15 and a period of performance through August 31, 2020. The contract was not set aside for any socioeconomic program. The purpose of the contract is not explicitly stated, but based on the agency and the location of performance in Buffalo, New York, it likely involves research and development or support services related to the Defense Health Agency's mission. Cleveland Biolabs, Inc. is the prime contractor, and there is no information provided about any subcontractors.

Quick answers

Who was awarded contract W81XWH15C0101?

W81XWH15C0101 was awarded to Cleveland Biolabs, Inc. by Medical Command (Department of the Army) on August 17, 2015.

How much is contract W81XWH15C0101 worth?

The government has obligated $3,558,603 on W81XWH15C0101.

Which agency awarded contract W81XWH15C0101?

Medical Command (Department of the Army) awarded W81XWH15C0101, with funding from Defense Health Agency (Department of Defense).

Was contract W81XWH15C0101 competed?

The extent of competition for W81XWH15C0101 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login